Nanosensors Startups

Siphox Health develops early diagnostic testing technology to detect and manage chronic diseases at home, delivered as a painless 5-minute test that enables frequent monitoring. The company targets the U.S. healthcare system to reduce the health and economic burden of chronic disease.

5 investors

Vena Vitals develops a noninvasive, continuous blood pressure monitoring device using patented sensor technology placed on the skin over an artery. The system targets anesthesiologists, sleep physicians, and hospitals for intraoperative, sleep disorder, and clinical monitoring applications.

4 investors

GTRACK Technologies develops fluorescent nanoparticle tracers used to map subsurface fluid flow in geothermal and oil and gas reservoirs.

2 investors

Amino Analytica designs rapid molecular diagnostic tests for emerging infectious diseases and biological threats, developed in weeks rather than the traditional 12+ months. The company combines point-of-care diagnostics technology with AI-driven bionanotechnology to enable earlier detection and faster pandemic response.

1 investor

PreDxion Bio develops rapid diagnostic tests using saliva samples and a scalable semiconductor-based platform, initially targeting SARS-CoV-2 detection for asymptomatic and presymptomatic individuals, with broader applications in monitoring immune response markers in critically ill patients and predicting complications from cell therapies.

1 investor